We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+12.33%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$15.6B
AUM Growth
+$1.15B
Cap. Flow
-$252M
Cap. Flow %
-1.61%
Top 10 Hldgs %
27.58%
Holding
750
New
44
Increased
354
Reduced
220
Closed
56

Top Buys

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$64.3M
2
AAPL icon
Apple
AAPL
+$53M
3
CRM icon
Salesforce
CRM
+$52.8M
4
AMAT icon
Applied Materials
AMAT
+$42.9M
5
MU icon
Micron Technology
MU
+$41.3M

Top Sells

Rank Stock Value
1
MRK icon
Merck
MRK
+$68.6M
2
ADBE icon
Adobe
ADBE
+$58.8M
3
ANSS
Ansys
ANSS
+$52.1M
4
TJX icon
TJX Companies
TJX
+$39.6M
5
TMO icon
Thermo Fisher Scientific
TMO
+$38.3M

Sector Composition

Rank Sector Weight
1 Technology 31.73%
2 Healthcare 28.37%
3 Financials 8.73%
4 Consumer Discretionary 8.29%
5 Industrials 6.97%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AME icon
426
Ametek
AME
$53.9B
$3.02M 0.02%
16,512
-1,068
-6% -$184K
JANX icon
427
Janux Therapeutics
JANX
$912M
$3.01M 0.02%
+80,005
New +$1.74M
MGA icon
428
Magna International
MGA
$18.8B
$2.98M 0.02%
54,577
+6,459
+13% +$356K
DHI icon
429
D.R. Horton
DHI
$41.2B
$2.92M 0.02%
17,750
-162
-0.9% -$24.3K
FWONK icon
430
Liberty Media Series C
FWONK
$25.5B
$2.92M 0.02%
44,480
-168,213
-79% -$11.3M
FTNT icon
431
Fortinet
FTNT
$112B
$2.91M 0.02%
42,649
-44,321
-51% -$2.95M
HUM icon
432
Humana
HUM
$43.9B
$2.91M 0.02%
8,380
-64,724
-89% -$24.5M
AFL icon
433
Aflac
AFL
$65.5B
$2.89M 0.02%
33,643
+324
+1% +$26.6K
GEN icon
434
Gen Digital
GEN
$16.5B
$2.87M 0.02%
128,335
+8,643
+7% +$192K
PPG icon
435
PPG Industries
PPG
$24.9B
$2.87M 0.02%
19,785
+1,401
+8% +$199K
NOMD icon
436
Nomad Foods
NOMD
$1.77B
$2.84M 0.02%
145,419
-12,840
-8% -$237K
NARI
437
DELISTED
Inari Medical, Inc. Common Stock
NARI
$2.84M 0.02%
+59,095
New +$3.16M
ROST icon
438
Ross Stores
ROST
$80.8B
$2.83M 0.02%
19,256
+1,311
+7% +$188K
CNI icon
439
Canadian National Railway
CNI
$78.5B
$2.82M 0.02%
21,389
+10,356
+94% +$1.32M
RAPT
440
DELISTED
RAPT Therapeutics
RAPT
$2.81M 0.02%
39,158
CPRT icon
441
Copart
CPRT
$28.5B
$2.76M 0.02%
47,722
+2,333
+5% +$120K
NDAQ icon
442
Nasdaq
NDAQ
$53.4B
$2.76M 0.02%
43,707
+7,960
+22% +$461K
IT icon
443
Gartner
IT
$11.1B
$2.75M 0.02%
5,773
+635
+12% +$292K
HPQ icon
444
HP
HPQ
$26B
$2.75M 0.02%
90,959
+11,952
+15% +$352K
TROW icon
445
T. Rowe Price
TROW
$25.5B
$2.73M 0.02%
22,366
-226
-1% -$25.2K
MLM icon
446
Martin Marietta Materials
MLM
$34.2B
$2.67M 0.02%
4,343
+303
+8% +$165K
SMCI icon
447
Super Micro Computer
SMCI
$16.6B
$2.66M 0.02%
+26,370
New +$1.93M
OXY icon
448
Occidental Petroleum
OXY
$55.7B
$2.64M 0.02%
40,670
-11,765
-22% -$703K
ACGL icon
449
Arch Capital
ACGL
$35.7B
$2.62M 0.02%
28,384
-62,860
-69% -$5.31M
PODD icon
450
Insulet
PODD
$11.8B
$2.62M 0.02%
15,260
+924
+6% +$172K

Similar funds

Candriam SCA's Q1 2024 Portfolio in Review

As of Q1 2024, Candriam SCA held 750 positions worth $15.6B, up 7.9% from $14.5B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Candriam SCA's Q1 2024 filing shows 44 new, 354 increased, 220 reduced and 56 closed positions. Its largest new stake was Altair Engineering Inc: 434,749 shares worth $37.5M. The largest sale was Merck, an estimated $68.6M.

By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 30% a quarter earlier, followed by Healthcare and Financials.

  • Candriam SCA's largest Q1 2024 buy was Altair Engineering Inc: 434,749 shares worth $37.5M.
  • Candriam SCA added most to NVIDIA in Q1 2024, an estimated $64.3M increase.
  • Candriam SCA's biggest Q1 2024 reduction was Merck, cutting an estimated $68.6M.
  • Candriam SCA fully exited Immunogen Inc in Q1 2024, selling an estimated $33.3M.
  • Candriam SCA's ten largest holdings make up 28% of its $15.6B portfolio in Q1 2024.
  • Candriam SCA opened 44 new positions and closed 56 in Q1 2024.
  • Candriam SCA's portfolio value rose 7.9% quarter-over-quarter to $15.6B.

Based on Candriam SCA's 13F filing for Q1 2024, filed 6 May 2024.